Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The biosimilars market size...
-
Pune, India, May 31, 2023 (GLOBE NEWSWIRE) -- The global ceramic balls market size was valued at USD 513.3 million in 2022 and is projected to reach a valuation of USD 533.9 million in 2023. The...
-
Proceeds to Accelerate Revenue Growth Through Sales Initiatives and Additional Product Launches Transformative Event Includes Conversion of Approximately $6 Million of Debt into Equity, $4.5 Million...
-
Redding, California, May 31, 2023 (GLOBE NEWSWIRE) -- Manufacturing Execution Systems Market by Offering (Software, Services), Deployment Mode, Process Industry, Discrete Industry and...
-
New York, May 31, 2023 (GLOBE NEWSWIRE) -- Global law firm Norton Rose Fulbright recently collaborated with Mergermarket to survey 200 senior executives from leading corporations and financial...
-
TARRYTOWN, N.Y., May 31, 2023 (GLOBE NEWSWIRE) -- Goody’s®, the fast acting, over-the-counter pain reliever in single dose powder form, announces the launch of its new national marketing campaign....
-
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- May 31, 2023 – Today, Sword Health, the world’s fastest growing pain solution, is announcing the launch of its platform to predict, prevent and treat pain....
-
BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Bicycle Health, the leading telehealth provider of integrated medical and behavioral health care for opioid use disorder (OUD) in the United States, today...
-
ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
-
WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial...